COVID-19 Reports

Table 1. COVID-19 reports
Report > COVID-19 Description
Rollout Plan Use this report to monitor coverage of COVID-19 vaccinations.

This report shows patients grouped in the following way:

  • More than two doses given already.
  • Two doses given already.
  • One dose given already.
  • Elderly adults aged 80 years and over.
  • Elderly adults aged 70-79 years.
  • Aboriginal and Torres Strait Islander people > 55.
  • Adults with an underlying medical condition.
  • Adults aged 60-69 years.
  • Adults aged 50-59 years.
  • Aboriginal and Torres Strait Islander people 18-54.
  • Adults aged 18-49 years.
  • Children aged 12-17 years.
  • Children aged 5-11 years.
  • Children aged 0-4 years.
  • [Other patients].

Each record shows the patient ID, name, sex, if Indigenous, whether they have a chronic condition in their clinical summary and if they are pregnant. It also shows a count of COVID-19 immunisations given, how many Pfizer doses, how many AstraZeneca doses and the number of cancellations. The last immunisation given is displayed and the earliest due recall is also displayed.

The report can be filtered by locality group, patient status, Indigenous status and age.

To show the following details, export to Microsoft Excel:
  • Patient's mobile phone if recorded and if not then the home phone and if this is unknown then the work phone
  • Date of birth
  • Age
  • Locality
  • Place where last COVID-19 immunisation was administered
  • Last non-COVID-19 immunisation given
  • Next recall for Consent;COVID-19 vaccination
Under-5s At Risk Shows clinical items recorded in a child’s record that may indicate that the child is a priority for getting COVID-19 vaccinations.

The report addresses the Australian Government Department of Health COVID-19 vaccination recommendation for some children aged 6 months to 4 years (dated 12 August 2022). Australia’s immunisation experts, the Australian Technical Advisory Group on Immunisation, recommend COVID-19 vaccination for children aged 6 months to 4 years with severe immunocompromise, disability, and those who have complex or multiple health conditions that increase their risk of severe COVID-19.

The clinical items used to compile this report are based on apparent alignment with the ICPC2+ codes and the ATAGI recommendations for inclusive conditions. It is not a definitive list, rather a tool to identify priority patients for review. The report identifies children who have a formal diagnosis identified with an ICPC2+ code. The items included are:
  • Items that are part of NEOPLASMS MALIGNANT ICPC2-groupers.
  • Items that are part of the CONGENITAL ANOMALY groupers for BLOOD, CARDIOVASCULAR, DIGESTIVE, NEUROLOGICAL, RESPIRATORY and NEUROLOGICAL and some from the MUSCULOSKELETAL grouper.
  • Items that are part of the DISABILITY groupers for BLOOD, CARDIOVASCULAR, DIGESTIVE, NEUROLOGICAL, RESPIRATORY and NEUROLOGICAL.
  • Items that are part of the GROWTH DELAY ICPC2-grouper.
  • Diabetes Type 1 and Type 2 items.
  • Coronary Heart Disease items.
  • Renal items.
  • Lung disorder items.
  • Behavioural items – ADHD, Autism, FASD, etc.